Additionally, pancreatic cancer vaccines using radiation-treated pancreatic cancer cells and GM-CSF to stimulate systemic anti-tumor immunity are currently being tested in clinical trials (4, 5). This evidence concerns the gene CSF2 and pancreatic neoplasm.